A-share CRO stocks extended gains: Hengdi Pharmaceutical and Ruizhi Medical hit the 20% daily limit; Nuoweizan rose >16%, Fuxiang Co. gained >11%, Dezhan Health up >9%.

Switzerland's foreign ministry said on June 22 it welcomed "constructive progress" in U.S.-Iran talks and is ready to support follow-up steps. It noted a joint statement by mediators Qatar and Pakistan and welcomed the "constructive progress" from intensive diplomatic talks on June 21-22 at Bürgenstock. The ministry said establishing a high-level committee under a memorandum of understanding is a "positive step" that will help plan the next political and technical phase, and that agreement on a roadmap to reach a final deal within 60 days creates conditions to begin technical-level discussions immediately. Switzerland said it will continue its mediation role and stands ready to assist.

PBOC conducted a CNY 524.5 bln 7-day reverse repo today; bid and accepted amounts were both CNY 524.5 bln, at a 1.40% rate, unchanged from the prior operation.